Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jun, 12 2026
Oct, 27 2025
May, 22 2026
Nov, 17 2025
Sep, 24 2025